Medicine & Life Sciences
Cell Transplantation
100%
Graft vs Host Disease
92%
Transplants
73%
Bone Marrow
66%
Transplantation
59%
Unrelated Donors
55%
Allogeneic Cells
55%
Bone Marrow Transplantation
53%
Tissue Donors
45%
Acute Myeloid Leukemia
38%
Survival
37%
Hematopoietic Stem Cell Transplantation
33%
Homologous Transplantation
31%
Recurrence
30%
Fetal Blood
29%
Leukemia
28%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
27%
Mortality
23%
Confidence Intervals
22%
Siblings
21%
Myelodysplastic Syndromes
15%
Survivors
14%
Cyclophosphamide
14%
Whole-Body Irradiation
13%
Autologous Transplantation
13%
Natural Killer Cells
12%
Therapeutics
12%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
12%
Stem Cell Transplantation
12%
Peripheral Blood Stem Cells
11%
Incidence
11%
Mycophenolic Acid
9%
Drug Therapy
9%
Clinical Trials
9%
Infections
9%
Transplant Recipients
9%
Allografts
9%
Disease-Free Survival
9%
Hematologic Neoplasms
9%
Non-Hodgkin's Lymphoma
8%
Multiple Myeloma
8%
KIR Receptors
8%
fludarabine
8%
Cytomegalovirus
7%
Antilymphocyte Serum
7%
HLA Antigens
7%
T-Lymphocytes
7%
Cytogenetics
6%
Steroids
6%
National Institutes of Health (U.S.)
6%